Wobenzym in the treatment
of patients with psoriasis
Milus I.E. Wobenzym in the treatment
of patients with psoriasis. Zurnal dermatologii i venerologii 1998,
2 (6), 35-36. Ukrainian.
58 patients (37 women, 21 men), aged 2-58 years, suffering from
various forms of psoriasis were observed. All patients underwent
complex, clinico-laboratory examination.
Patients were divided into 4 groups:
·
Control - 15 patients, received a conventional therapy (vitamins,
biostimulators, immunocorrectors, fyziotherapy, and softening
ointments).
·
Complex treatment including Wobenzym (3 tablets 3 times a day for 30
days) - 16 patients
·
Complex therapy including external application of Wobe Mugos
ointment - 6 patients
·
Complex therapy including both Wobenzym and Wobe Mugos - 21 patients
Treatment was well tolerated by all patients. In patients in groups
2 and 4, receiving Wobenzym, a significant decrease of exsudative
component of exacerbation was observed after 3-5 days of treatment.
Resting stage of the disease occurred in group 1 after 7-9 days of
treatment, in patients in groups 2 and 4 after 3-5 days. Complete
regression was achieved in group 1 after 28-32 days of treatment, in
group 2 after 24-26 days, in group 3 after 26-28 days, and in group
4 after 18-20 days. Dynamics as well as the exacerbation regression
were accompanied by a marked tendency to the normalization of
biochemical, immunological parameters (most significant in groups 2
and 4).